Page 3 - Rami Komrokji News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Komrokji on Ongoing Studies in Higher- and Lower-Risk MDS

Rami Komrokji, MD, discusses ongoing clinical trials in patients with higher- and lower-risk myelodysplastic syndromes.

Moffitt cancer centerMedicine oncologic sciencesMalignant hematology departmentUniversity of south floridaExperimental therapeutics programCollege of medicineRami komrokjiMalignant hematologyOncologic sciencesSouth floridaMyeloproliferative neoplasmsOnclive tv

Educated Patient® MPN Summit Myelofibrosis Panel: May 20, 2023

Educated Patient® MPN Summit Myelofibrosis Panel: May 20, 2023
curetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from curetoday.com Daily Mail and Mail on Sunday newspapers.

United kingdomBrielle benyonJohno mascarenhasIcahn school of medicineMoffitt cancer centerRami komrokjiIcahn school

Educated Patient® MPN Summit Risk Stratification and Management of MF Presentation: May 20, 2023

Educated Patient® MPN Summit Risk Stratification and Management of MF Presentation: May 20, 2023
curetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from curetoday.com Daily Mail and Mail on Sunday newspapers.

United statesMoffitt cancer centerDrug administrationRami komrokjiEducated patient

Emerging Data Offer Alternatives for Patients With Lower-Risk MDS

Frontline treatments that achieve transfusion independence are of paramount importance for patients with lower-risk myelodysplastic syndrome.

United statesGuillermo garcia maneroAmy elizabeth dezernUwe platzbeckerSamer zeidanAmerican society of hematologyOnclive the talkRami komrokjiAmerican societyElizabeth dezernMyeloproliferative neoplasmsMoffitt cancer center